David Horn Sells 7,303 Shares of Seer (NASDAQ:SEER) Stock

Seer, Inc. (NASDAQ:SEER) CFO David Horn sold 7,303 shares of the company’s stock in a transaction on Wednesday, May 20th. The stock was sold at an average price of $1.69, for a total value of $12,342.07. Following the sale, the chief financial officer owned 493,959 shares of the company’s stock, valued at approximately $834,790.71. The trade was a 1.46% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Seer Stock Up 1.1%

SEER stock opened at $1.79 on Friday. The company has a market cap of $100.99 million, a price-to-earnings ratio of -1.44 and a beta of 1.63. The business has a fifty day simple moving average of $1.80 and a 200-day simple moving average of $1.87. Seer, Inc. has a 52 week low of $1.65 and a 52 week high of $2.41.

Seer (NASDAQ:SEER) last released its quarterly earnings data on Wednesday, May 13th. The company reported ($0.30) EPS for the quarter, hitting analysts’ consensus estimates of ($0.30). The business had revenue of $2.79 million during the quarter, compared to the consensus estimate of $3.60 million. Seer had a negative return on equity of 26.58% and a negative net margin of 464.78%.

Analyst Upgrades and Downgrades

SEER has been the subject of a number of research reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Seer in a research report on Tuesday, April 21st. TD Cowen raised shares of Seer to a “strong-buy” rating in a research report on Monday, April 13th. Finally, Canaccord Genuity Group initiated coverage on shares of Seer in a research report on Monday, May 4th. They set a “buy” rating and a $4.00 price target for the company. Two research analysts have rated the stock with a Strong Buy rating and one has given a Sell rating to the company. According to data from MarketBeat, Seer presently has a consensus rating of “Buy” and an average target price of $4.00.

Institutional Trading of Seer

A number of institutional investors have recently added to or reduced their stakes in SEER. Nano Cap New Millennium Growth Fund L P purchased a new stake in Seer during the 4th quarter worth $1,510,000. Rangeley Capital LLC boosted its position in Seer by 821.5% during the 1st quarter. Rangeley Capital LLC now owns 184,302 shares of the company’s stock worth $310,000 after purchasing an additional 164,302 shares during the period. T3 Companies LLC purchased a new stake in Seer during the 4th quarter worth $242,000. Bridgeway Capital Management LLC boosted its position in Seer by 15.5% during the 2nd quarter. Bridgeway Capital Management LLC now owns 837,443 shares of the company’s stock worth $1,792,000 after purchasing an additional 112,100 shares during the period. Finally, XTX Topco Ltd purchased a new stake in Seer during the 2nd quarter worth $172,000. 75.20% of the stock is owned by hedge funds and other institutional investors.

About Seer

Seer, Inc is a life sciences company focused on pioneering next-generation proteomics, the large-scale study of proteins and their functions in complex biological systems. By leveraging proprietary nanoparticle-based technology, Seer’s platform enables high-throughput, unbiased protein analysis from biological samples, addressing a critical bottleneck in drug discovery, biomarker research and precision medicine.

The company’s flagship Proteograph Product Suite combines engineered nanoparticle assays with advanced mass spectrometry and bioinformatics pipelines to deliver deep proteomic coverage in a scalable workflow.